Acadian Asset Management’s Protalix BioTherapeutics PLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
Sell
-9,691
Closed -$24K 1794
2025
Q1
$24K Buy
+9,691
New +$24K ﹤0.01% 1517